Critical Choices for Improving Outcomes in Renal Cell Carcinoma

Archived Webcast
	Click here to view!
Estimated time to complete activity: 2 hours \| Release date: June 5, 2009 \| Expiration date: June 4, 2010

Faculty

Bernard J. Escudier, MD Co-Chair
Head, Immunotherapy Unit
Institut Gustave Roussy
Villejuif, France

Robert A. Figlin, MD, FACP Co-Chair
Acting Director and Associate Director for Clinical Research, Comprehensive Cancer Center
Arthur and Rosalie Kaplan Chair in Medical Oncology Endowed Chair
Chair, Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California, USA

Brian I. Rini, MD
Associate Professor of Medicine CCF/CWRU Lerner College of Medicine
Department of Solid Tumor Oncology
Glickman Urological Institute
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio, USA

Cora N. Sternberg, MD, FACP
Chief, Department of Medical Oncology
San Camillo Forlanini Hospitals
Rome, Italy

Questions?
Jackie Falconer
jfalconer@educationalconcepts.net
1.866.933.1696
Educational Concepts Group, LLC
1300 Parkwood Circle SE | Suite 325
Atlanta, GA 30339

Featured Topics - Download Slides Participants must view each section in its entirety to receive full credit for this program.
	Newly Diagnosed Renal Cell Carcinoma – Examination of the Role of Nephrectomy and Neoadjuvant Therapy
	First-Line Management of Advanced Clear Cell Disease – Examination of Therapies and Options
	Optimal First-Line Treatment for Papillary Tumors
	Best Practices for the Management of Relapsed/Refractory RCC

Claim Credit
	Physicians click here to complete post-test and evaluation
	Click here to claim certificate

None of the contents may be reproduced in any form without prior written permission from the publisher. This activity may be accessed at www.educationalconcepts.net.

This activity is sponsored by

This activity is supported by an educational grant from